Quantbot Technologies LP Sells 1,439 Shares of Danaher Co. (NYSE:DHR)

Quantbot Technologies LP cut its stake in shares of Danaher Co. (NYSE:DHR) by 13.9% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 8,901 shares of the conglomerate’s stock after selling 1,439 shares during the period. Quantbot Technologies LP’s holdings in Danaher were worth $2,223,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Cary Street Partners Investment Advisory LLC raised its position in shares of Danaher by 20.2% in the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 9,128 shares of the conglomerate’s stock valued at $2,112,000 after acquiring an additional 1,533 shares during the period. First Citizens Bank & Trust Co. boosted its position in shares of Danaher by 0.6% during the fourth quarter. First Citizens Bank & Trust Co. now owns 26,611 shares of the conglomerate’s stock worth $6,156,000 after purchasing an additional 149 shares in the last quarter. Cercano Management LLC grew its holdings in shares of Danaher by 11.4% in the 4th quarter. Cercano Management LLC now owns 202,569 shares of the conglomerate’s stock valued at $46,862,000 after buying an additional 20,715 shares during the period. Allspring Global Investments Holdings LLC increased its position in shares of Danaher by 48.1% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 296,996 shares of the conglomerate’s stock valued at $68,707,000 after buying an additional 96,395 shares in the last quarter. Finally, Donaldson Capital Management LLC raised its stake in Danaher by 5.8% during the 1st quarter. Donaldson Capital Management LLC now owns 1,469 shares of the conglomerate’s stock worth $367,000 after buying an additional 80 shares during the period. Institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

A number of research firms have issued reports on DHR. StockNews.com cut Danaher from a “buy” rating to a “hold” rating in a research note on Tuesday, June 25th. TD Cowen increased their target price on Danaher from $280.00 to $290.00 and gave the stock a “buy” rating in a research note on Wednesday, April 24th. Barclays lifted their price target on shares of Danaher from $260.00 to $270.00 and gave the company an “equal weight” rating in a research note on Wednesday, April 24th. Robert W. Baird increased their price objective on shares of Danaher from $259.00 to $271.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 24th. Finally, Citigroup boosted their price objective on shares of Danaher from $280.00 to $290.00 and gave the company a “buy” rating in a research report on Wednesday, April 24th. Six research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat, Danaher presently has an average rating of “Moderate Buy” and an average target price of $268.67.

Danaher Stock Up 0.2 %

DHR stock traded up $0.43 during mid-day trading on Friday, reaching $246.70. The company had a trading volume of 2,519,556 shares, compared to its average volume of 2,859,258. Danaher Co. has a 52 week low of $182.09 and a 52 week high of $269.11. The company has a market capitalization of $182.73 billion, a price-to-earnings ratio of 41.81, a PEG ratio of 3.70 and a beta of 0.83. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.85 and a quick ratio of 1.51. The stock has a 50 day simple moving average of $255.05 and a two-hundred day simple moving average of $247.31.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 earnings per share for the quarter, topping analysts’ consensus estimates of $1.72 by $0.20. The business had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.62 billion. Danaher had a net margin of 16.78% and a return on equity of 11.43%. The firm’s revenue for the quarter was down 2.6% on a year-over-year basis. During the same period in the previous year, the company earned $2.36 earnings per share. As a group, equities analysts predict that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be paid a $0.27 dividend. The ex-dividend date of this dividend is Friday, June 28th. This represents a $1.08 annualized dividend and a yield of 0.44%. Danaher’s dividend payout ratio (DPR) is currently 18.31%.

Insider Buying and Selling

In other news, CEO Rainer Blair sold 9,005 shares of the firm’s stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $265.00, for a total value of $2,386,325.00. Following the completion of the sale, the chief executive officer now directly owns 106,990 shares of the company’s stock, valued at $28,352,350. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other news, CEO Rainer Blair sold 9,005 shares of the stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $265.00, for a total value of $2,386,325.00. Following the transaction, the chief executive officer now directly owns 106,990 shares of the company’s stock, valued at $28,352,350. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Matthew Mcgrew sold 46,377 shares of Danaher stock in a transaction dated Friday, May 10th. The stock was sold at an average price of $253.05, for a total transaction of $11,735,699.85. Following the sale, the chief financial officer now directly owns 29,407 shares of the company’s stock, valued at approximately $7,441,441.35. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 148,783 shares of company stock worth $37,536,717. Company insiders own 11.10% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.